In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species

Journal of Infection and Chemotherapy

Volumn 17, Issue 5, 2011, Pages 634-639

  Öncu, Serkan ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Antibiotic lock; Antifungals; Candida; Catheter

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDIASIS; CATHETER INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; FUNGAL COLONIZATION; FUNGAL DETECTION; IN VITRO STUDY; INSTRUMENT STERILIZATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 84855434494     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-011-0224-3     Document Type: Article

References (24)

1. Oncu S, Ozsut H, Yildirim A, Ay P, Cakar N, Eraksoy H, et al. Central venous catheter related infections: Risk factors and the effect of glycopeptide antibiotics. Ann Clin Microbiol Antimicrob. 2003;2:3.
2. Bouza E, Burillo A, Munoz P. Catheter-related infections: Diagnosis and intravascular treatment. Clin Microbiol Infect. 2002;8:265-74. (Pubitemid 34993797)
3. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1-45.
4. Wenzel RP. Nosocomial candidemia: Risk factors and attributable mortality. Clin Infect Dis. 1995;20:1531-4.
5. Carratala J. The antibiotic-lock technique for therapy of 'highly needed' infected catheters. Clin Microbiol Infect. 2002;8:282-9. (Pubitemid 34993799)
6. Oncu S, Ozturk B, Kurt I, Sakarya S. Elimination of intraluminal colonization by antibiotic lock in catheters. Tohoku J Exp Med. 2004;203:1-8. (Pubitemid 38832649)
7. Shin JH, Kee SJ, Shin MG, Kim SH, Shin DH, Lee SK, et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: Comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol. 2002;40:1244-8. (Pubitemid 34279883)
8. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard. 2nd edn. Wayne: National Committee for Clinical Laboratory Standards; 2002.
9. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother. 2001;45:999-1007. (Pubitemid 32230975)
10. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin Infect Dis. 2002;34:591-9. (Pubitemid 34165320)
11. Viale P, Petrosillo N, Signorini L, Puoti M, Carosi G. Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections? Clin Infect Dis 2001;33:1947-8 (author reply 1949-1951). (Pubitemid 33105140)
12. Buckler BS, Sams RN, Goei VL, Krishnan KR, Bemis MJ, Parker DP, et al. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy. Pediatr Infect Dis J. 2008;27:762-4.
13. Andris DA, Krzywda EA, Edmiston CE, Krepel CJ, Gohr CM. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition. 1998;14:427-32. (Pubitemid 28264708)
14. Shuford JA, Rouse MS, Piper KE, Steckelberg JM, Patel R. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis. 2006;194:710-3. (Pubitemid 44297859)
15. Cateau E, Rodier MH, Imbert C. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. J Antimicrob Chemother. 2008;62:153-5. (Pubitemid 351865889)
16. Schinabeck MK, Long LA, Hossain MA, Chandra J, Mukherjee PK, Mohamed S, et al. Rabbit model of Candida albicans biofilm infection: Liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother. 2004;48:1727-32. (Pubitemid 38544381)
17. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, et al. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance. J Clin Microbiol. 2008;46:150-6.
18. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004;17:255-67. (Pubitemid 38534029)
19. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001;45:2475-9. (Pubitemid 32801898)
20. Baillie GS, Douglas LJ. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol. 1999;310:644-56. (Pubitemid 29504312)
21. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother. 2002;46:3634-6. (Pubitemid 35192940)
22. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother. 2002;46:1773-80. (Pubitemid 34535196)
23. Falci DR, Lunardi LW, Ramos CG, Bay MB, Aquino VR, Goldani LZ. Continuous infusion of amphotericin B deoxycholate in the treatment of cryptococcal meningoencephalitis: Analysis of safety and fungicidal activity. Clin Infect Dis. 2010;50:e26-9.
24. Oncu S, Sakarya S. Comparison of different dosages of vancomycin and teicoplanin in catheters infected with Staphylococcus epidermidis: An in vitro antibiotic lock study. Curr Ther Res. 2004;66:364-74. (Pubitemid 41433265)